(-0.08%) 5 304.00 points
(-0.03%) 40 133 points
(-0.11%) 18 483 points
(1.35%) $82.45
(-0.35%) $1.712
(0.76%) $2 229.60
(-0.36%) $24.66
(0.04%) $910.05
(0.41%) $0.927
(0.73%) $10.85
(0.20%) $0.793
(-0.17%) $92.28
5 days till quarter result
(bmo 2024-04-02)
Expected move: +/- 12.55%
Live Chart Being Loaded With Signals
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States...
Stats | |
---|---|
Today's Volume | 9 852.00 |
Average Volume | 21 537.00 |
Market Cap | 11.30M |
EPS | $-0.780 ( 2023-11-13 ) |
Next earnings date | ( $0 ) 2024-04-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.590 |
ATR14 | $0.0410 (1.47%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-02 | Rao Veena | Buy | 1 875 | Common Stock |
2023-10-02 | Handley Daniel E | Buy | 1 875 | Common Stock |
2023-10-02 | St. Clair Gregory Sr | Buy | 1 875 | Common Stock |
2023-10-02 | Chung-welch Nancy | Buy | 1 875 | Common Stock |
2023-10-02 | Hawryluk Matthew | Buy | 1 875 | Common Stock |
INSIDER POWER |
---|
97.09 |
Last 95 transactions |
Buy: 2 265 801 | Sell: 54 044 |
Predictive Oncology Inc Correlation
10 Most Positive Correlations | |
---|---|
RPAY | 0.829 |
VNQI | 0.828 |
LDEM | 0.826 |
SLQD | 0.823 |
IGSB | 0.823 |
SKOR | 0.823 |
IGIB | 0.817 |
SBUX | 0.815 |
GTH | 0.815 |
RGLD | 0.815 |
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Predictive Oncology Inc Financials
Annual | 2022 |
Revenue: | $1.51M |
Gross Profit: | $1.00M (66.45 %) |
EPS: | $-0.500 |
Q3 | 2023 |
Revenue: | $715 056 |
Gross Profit: | $608 116 (85.04 %) |
EPS: | $-0.780 |
Q2 | 2023 |
Revenue: | $490 110 |
Gross Profit: | $330 349 (67.40 %) |
EPS: | $-0.980 |
Q1 | 2023 |
Revenue: | $239 895 |
Gross Profit: | $119 756 (49.92 %) |
EPS: | $-1.070 |
Financial Reports:
No articles found.
Predictive Oncology Inc
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators